Skip to main content
Premium Trial:

Request an Annual Quote

Microarray-based NIPT Firm CellScape Shuts Down

NEW YORK (GenomeWeb) – Microarray-based non-invasive prenatal testing firm CellScape has shut down.

According to its LinkedIn page, the company, which had been headquartered in Newark, Calif., ceased operations in September.

CellScape was founded in 2008 and was developing an NIPT using chromosomal microarrays for detecting fetal aneuploidies, as well as genetic disorders that generally have required invasive methods. In 2013, company officials told GenomeWeb Daily News that the firm planned to launch its test called Clarity in the second half of this year. That target date was later pushed back to 2015.

According to its LinkedIn page, CellScape had between 11 and 50 employees. Its founders were Karen Drexler, Bhairavi Parikh, and James Stone.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.